EVIO Inc., (OTCQB: EVIO), a leading North American provider of cannabis testing and scientific research for the regulated cannabis industry, is excited to announce EVIO Biosciences launches the release of the first Genomics Testing program for Pathogen Identification in Cannabis.
Read more
EVIO Biosciences Launches the World’s First Genomics Testing Program for Pathogen Identification in Cannabis
